Monotherapy for Rheumatoid Arthritis: Leveraging the Latest Evidence to Treat to Target

In this downloadable slideset, Jonathan Scott Coblyn, MD; Jessica Farrell, PharmD; and Frances Griffin, RN, BSN, provide an overview of best practices in the use of monotherapy to treat rheumatoid arthritis.
Jonathan Scott Coblyn, MD
Program Director
Jessica Farrell, PharmD
Frances Griffin, RN, BSN
Format: Microsoft PowerPoint (.ppt)
File Size: 346 KB
Released: June 29, 2018

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Pfizer

Related Content

Expert slides from Clinical Care Options (CCO) on optimal management of inflammatory bowel disease (IBD), including ulcerative colitis, Crohn disease

Uma Mahadevan, MD William Sandborn, MD Released: September 22, 2020

Efficacy, safety of baricitinib in patients with moderate to severe atopic dermatitis in BREEZE-AD5: atopic dermatitis conference coverage from CCO

Released: August 11, 2020

Enter asthma patient characteristics in this online CCO tool and compare your treatment plan with those of 5 experts

Michael E. Wechsler, MD, MMSc
Program Director
Bradley E. Chipps, MDFAAP, FACAAI, FAAAAI, FCCP Nicola Alexander Hanania, MD, MS Linda Rogers, MD Eileen Wang, MD, MPH
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: August 5, 2020 Expired: August 4, 2021

Effect of withdrawal and retreatment with upadacitinib during an interim analysis of the 88-week phase 2b trial, from CCO

Released: July 27, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue